Aditxt is a biotech company that develops technologies to improve immune system health through immune mapping and reprogramming. Its AditxtScore allows individuals to monitor their immune profiles, and it is developing nucleic acid-based technology for organ transplantation, autoimmune diseases, and allergies. The company has license agreements with Loma Linda University and Leland Stanford Junior University and is headquartered in Richmond, Virginia.